Life with migraine in patients’ own words
A new study describes life with migraine in patients’ own words. It’s like reading a patient’s story, but it’s data!
News & Research
-
-
Migraine World Summit Starts Wednesday, March 17
Learn from experts for free at the online Migraine World Summit, March 17–25, 2021.
-
SpringTMS, sTMS mini no longer available?
The maker of SpringTMS and sTMS mini, eNeura, filed for Chapter 7 bankruptcy on Friday, August 7. In Chapter 7 bankruptcy, companies liquidate their assets, so this doesn’t look good for short-term access to SpringTMS. I don’t know anything for certain, though—all the information I…
-
gammaCore for Migraine Received FDA Approval!
The gammaCore is an external vagus nerve stimulator that can be used to treat migraine and cluster headache. It received FDA approval for cluster headache last summer and was approved for migraine today. It’s also the new treatment I’ve been using since June 2016 and…
-
CGRP Drug for Chronic Migraine: Very Promising Study Results
Amgen’s CGRP drug provided significant relief to participants with chronic migraine, according to new study results presented at an international conference in mid-September. The drug, called erenumab, was tested at two doses, 70 mg and 140 mg. “Both doses of erenumab were associated with significant…
